Alpha-synuclein aggregation involves a bafilomycin A₁-sensitive autophagy pathway

References

• Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388:839 - 40; http://dx.doi.org/10.1038/42166; PMID: 9278044
   PubMed Web of Science ®Google Scholar
• Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch MP, et al. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol 2006; 111:101 - 8; http://dx.doi.org/10.1007/s00401-005-0027-7; PMID: 16482476
   PubMed Web of Science ®Google Scholar
• Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson’s disease. Science 2003; 302:819 - 22; http://dx.doi.org/10.1126/science.1087753; PMID: 14593166
   PubMed Web of Science ®Google Scholar
• Jaeger PA, Wyss-Coray T. All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Mol Neurodegener 2009; 4:16; http://dx.doi.org/10.1186/1750-1326-4-16; PMID: 19348680
   PubMed Web of Science ®Google Scholar
• Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol Histopathol 1997; 12:25 - 31; PMID: 9046040
   PubMed Web of Science ®Google Scholar
• Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003; 278:25009 - 13; http://dx.doi.org/10.1074/jbc.M300227200; PMID: 12719433
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004; 305:1292 - 5; http://dx.doi.org/10.1126/science.1101738; PMID: 15333840
   PubMed Web of Science ®Google Scholar
• Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT, et al. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci 2011; 31:14508 - 20; http://dx.doi.org/10.1523/JNEUROSCI.1560-11.2011; PMID: 21994367
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006; 443:780 - 6; http://dx.doi.org/10.1038/nature05291; PMID: 17051204
   PubMed Web of Science ®Google Scholar
• Dice JF. Chaperone-mediated autophagy. Autophagy 2007; 3:295 - 9; PMID: 17404494
   PubMed Web of Science ®Google Scholar
• Dunn WA Jr.. Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J Cell Biol 1990; 110:1935 - 45; http://dx.doi.org/10.1083/jcb.110.6.1935; PMID: 2161853
   PubMed Web of Science ®Google Scholar
• Lee HJ, Khoshaghideh F, Patel S, Lee SJ. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004; 24:1888 - 96; http://dx.doi.org/10.1523/JNEUROSCI.3809-03.2004; PMID: 14985429
   PubMed Web of Science ®Google Scholar
• Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 2009; 4:e5515; http://dx.doi.org/10.1371/journal.pone.0005515; PMID: 19436756
   PubMed Web of Science ®Google Scholar
• Yu WH, Dorado B, Figueroa HY, Wang L, Planel E, Cookson MR, et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am J Pathol 2009; 175:736 - 47; http://dx.doi.org/10.2353/ajpath.2009.080928; PMID: 19628769
   PubMed Web of Science ®Google Scholar
• Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ. Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem 2004; 279:25497 - 502; http://dx.doi.org/10.1074/jbc.M400255200; PMID: 15044495
   PubMed Web of Science ®Google Scholar
• Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 2002; 295:865 - 8; http://dx.doi.org/10.1126/science.1067389; PMID: 11823645
   PubMed Web of Science ®Google Scholar
• Klucken J, Outeiro TF, Nguyen P, McLean PJ, Hyman BT. Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J 2006; 20:2050 - 7; http://dx.doi.org/10.1096/fj.05-5422com; PMID: 17012257
   PubMed Web of Science ®Google Scholar
• Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000; 287:1265 - 9; http://dx.doi.org/10.1126/science.287.5456.1265; PMID: 10678833
   PubMed Web of Science ®Google Scholar
• Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson’s and Lewy body diseases. J Neurosci 2009; 29:13578 - 88; http://dx.doi.org/10.1523/JNEUROSCI.4390-09.2009; PMID: 19864570
   PubMed Web of Science ®Google Scholar
• Shin Y, Klucken J, Patterson C, Hyman BT, McLean PJ. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem 2005; 280:23727 - 34; http://dx.doi.org/10.1074/jbc.M503326200; PMID: 15845543
   PubMed Web of Science ®Google Scholar
• Higashi S, Moore DJ, Minegishi M, Kasanuki K, Fujishiro H, Kabuta T, et al. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies. J Neuropathol Exp Neurol 2011; 70:264 - 80; http://dx.doi.org/10.1097/NEN.0b013e318211c86a; PMID: 21412173
   PubMed Web of Science ®Google Scholar
• Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K. Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol Dis 2011; 43:690 - 7; http://dx.doi.org/10.1016/j.nbd.2011.05.022; PMID: 21684337
   PubMed Web of Science ®Google Scholar
• Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 2010; 5:e9313; http://dx.doi.org/10.1371/journal.pone.0009313; PMID: 20174468
   PubMed Web of Science ®Google Scholar
• McLean PJ, Kawamata H, Hyman BT. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 2001; 104:901 - 12; http://dx.doi.org/10.1016/S0306-4522(01)00113-0; PMID: 11440819
   PubMed Web of Science ®Google Scholar
• Shacka JJ, Klocke BJ, Roth KA. Autophagy, bafilomycin and cell death: the “a-B-cs” of plecomacrolide-induced neuroprotection. Autophagy 2006; 2:228 - 30; PMID: 16874105
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007; 6:304 - 12; http://dx.doi.org/10.1038/nrd2272; PMID: 17396135
   PubMed Web of Science ®Google Scholar
• Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 2003; 278:44405 - 11; http://dx.doi.org/10.1074/jbc.M308041200; PMID: 12923179
   PubMed Web of Science ®Google Scholar
• Shao E, Forgac M. Involvement of the nonhomologous region of subunit A of the yeast V-ATPase in coupling and in vivo dissociation. J Biol Chem 2004; 279:48663 - 70; http://dx.doi.org/10.1074/jbc.M408278200; PMID: 15355963
   PubMed Web of Science ®Google Scholar
• Dehay B, Bové J, Rodríguez-Muela N, Perier C, Recasens A, Boya P, et al. Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci 2010; 30:12535 - 44; http://dx.doi.org/10.1523/JNEUROSCI.1920-10.2010; PMID: 20844148
   PubMed Web of Science ®Google Scholar
• Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA. Lysosomal degradation of alpha-synuclein in vivo. J Biol Chem 2010; 285:13621 - 9; http://dx.doi.org/10.1074/jbc.M109.074617; PMID: 20200163
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 2010; 67:1464 - 72; http://dx.doi.org/10.1001/archneurol.2010.198; PMID: 20697033
   PubMed Web of Science ®Google Scholar
• Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH. Alterations in lysosomal and proteasomal markers in Parkinson’s disease: relationship to alpha-synuclein inclusions. Neurobiol Dis 2009; 35:385 - 98; http://dx.doi.org/10.1016/j.nbd.2009.05.023; PMID: 19505575
   PubMed Web of Science ®Google Scholar
• Ni-Komatsu L, Tong C, Chen G, Brindzei N, Orlow SJ. Identification of quinolines that inhibit melanogenesis by altering tyrosinase family trafficking. Mol Pharmacol 2008; 74:1576 - 86; http://dx.doi.org/10.1124/mol.108.050633; PMID: 18801917
   PubMed Web of Science ®Google Scholar
• Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, et al. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. J Neurosci Res 2005; 80:247 - 59; http://dx.doi.org/10.1002/jnr.20446; PMID: 15765523
   PubMed Web of Science ®Google Scholar
• Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 2001; 21:9549 - 60; PMID: 11739566
   PubMed Web of Science ®Google Scholar
• Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 2008; 118:777 - 88; PMID: 18172548
   PubMed Web of Science ®Google Scholar
• Williams A, Jahreiss L, Sarkar S, Saiki S, Menzies FM, Ravikumar B, et al. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 2006; 76:89 - 101; http://dx.doi.org/10.1016/S0070-2153(06)76003-3; PMID: 17118264
   PubMed Web of Science ®Google Scholar
• Hunke S, Döse S, Schneider E. Vanadate and bafilomycin A1 are potent inhibitors of the ATPase activity of the reconstituted bacterial ATP-binding cassette transporter for maltose (MalFGK2). Biochem Biophys Res Commun 1995; 216:589 - 94; http://dx.doi.org/10.1006/bbrc.1995.2663; PMID: 7488152
   PubMed Web of Science ®Google Scholar
• Sharom FJ, Yu X, Chu JW, Doige CA. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochem J 1995; 308:381 - 90; PMID: 7772017
   PubMed Web of Science ®Google Scholar
• Teplova VV, Tonshin AA, Grigoriev PA, Saris NE, Salkinoja-Salonen MS. Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions. J Bioenerg Biomembr 2007; 39:321 - 9; http://dx.doi.org/10.1007/s10863-007-9095-9; PMID: 17917797
   PubMed Web of Science ®Google Scholar
• Shacka JJ, Klocke BJ, Shibata M, Uchiyama Y, Datta G, Schmidt RE, et al. Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons. Mol Pharmacol 2006; 69:1125 - 36; http://dx.doi.org/10.1124/mol.105.018408; PMID: 16391239
   PubMed Web of Science ®Google Scholar
• González-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquère S, et al. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci 2005; 118:3091 - 102; http://dx.doi.org/10.1242/jcs.02447; PMID: 15985464
   PubMed Web of Science ®Google Scholar
• Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, et al. Small molecules enhance autophagy and reduce toxicity in Huntington’s disease models. Nat Chem Biol 2007; 3:331 - 8; http://dx.doi.org/10.1038/nchembio883; PMID: 17486044
   PubMed Web of Science ®Google Scholar
• Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 2007; 282:5641 - 52; http://dx.doi.org/10.1074/jbc.M609532200; PMID: 17182613
   PubMed Web of Science ®Google Scholar
• McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113 - 24; PMID: 8909416
   PubMed Web of Science ®Google Scholar
• Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 2002; 68:568 - 78; http://dx.doi.org/10.1002/jnr.10231; PMID: 12111846
   PubMed Web of Science ®Google Scholar
• Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, et al. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E. Exp Neurol 2001; 170:15 - 26; http://dx.doi.org/10.1006/exnr.2001.7684; PMID: 11421580
   PubMed Web of Science ®Google Scholar
• Kawamata H, McLean PJ, Sharma N, Hyman BT. Interaction of alpha-synuclein and synphilin-1: effect of Parkinson’s disease-associated mutations. J Neurochem 2001; 77:929 - 34; http://dx.doi.org/10.1046/j.1471-4159.2001.00301.x; PMID: 11331421
   PubMed Web of Science ®Google Scholar
• Pedraza CE, Bassett DC, McKee MD, Nelea V, Gbureck U, Barralet JE. The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection. Biomaterials 2008; 29:3384 - 92; http://dx.doi.org/10.1016/j.biomaterials.2008.04.043; PMID: 18485472
   PubMed Web of Science ®Google Scholar
• Van Agtmael T, Schlötzer-Schrehardt U, McKie L, Brownstein DG, Lee AW, Cross SH, et al. Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum Mol Genet 2005; 14:3161 - 8; http://dx.doi.org/10.1093/hmg/ddi348; PMID: 16159887
   PubMed Web of Science ®Google Scholar
• Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, et al. Progressive accumulation of amyloid-beta oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J 2010; 277:3051 - 67; http://dx.doi.org/10.1111/j.1742-4658.2010.07719.x; PMID: 20573181
   PubMed Web of Science ®Google Scholar